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There is a growing interest in the role of biological and behavioral rhythms in typical and
atypical development. Recent studies in cognitive and developmental psychology have
highlighted the importance of rhythmicity and synchrony of motor, emotional, and inter-
personal rhythms in early development of social communication. The synchronization of
rhythms allows tuning and adaptation to the external environment.The role of melatonin in
the ontogenetic establishment of circadian rhythms and the synchronization of the circa-
dian clocks network suggests that this hormone might be also involved in the synchrony of
motor, emotional, and interpersonal rhythms. Autism provides a challenging model of phys-
iological and behavioral rhythm disturbances and their possible effects on the development
of social communication impairments and repetitive behaviors and interests. This article
situates autism as a disorder of biological and behavioral rhythms and reviews the recent
literature on the role of rhythmicity and synchrony of rhythms in child development. Finally,
the hypothesis is developed that an integrated approach focusing on biological, motor,
emotional, and interpersonal rhythms may open interesting therapeutic perspectives for
children with autism. More specifically, promising avenues are discussed for potential ther-
apeutic benefits in autism spectrum disorder of melatonin combined with developmental
behavioral interventions that emphasize synchrony, such as the Early Start Denver Model.
Keywords: autism spectrum disorder, biological rhythms, motor, emotional and relational rhythms, synchronization
of rhythms, melatonin, Early Start Denver Model, therapeutics
INTRODUCTION
Endogenous physiological variations involved in biological
rhythms reflect adaptation to the environment. Thus, the sleep–
wake rhythm associated with biological circadian rhythms can be
viewed as an adaptation to the day–night cycle. Circadian rhythms
allow temporal organization of biological functions in relation to
environmental changes (1). The periodicity of activities applies to
all biological, physiological, and psychological functions; recently,
the science of biological rhythms, chronobiology, has emerged
with its own theory, science, and education (2).
Furthermore, recent studies in the field of cognitive and
developmental psychology have highlighted the importance of
rhythmicity and synchrony of motor, emotional, and relational
rhythms in early development of social communication. Given
the major role of the sleep hormone melatonin in the ontogenetic
establishment of diurnal rhythms, the synchronization of periph-
eral oscillators (also termed clocks) and the regulation of human
circadian rhythms (1), melatonin might be involved in the
synchrony of motor, emotional, and relational rhythms.
Indeed, relationships might exist, based on the hypothesis of
ergodicity (3), between cellular communication networks involv-
ing a cellular synchrony (synchronization of cellular oscillations by
melatonin) and early social communication development involv-
ing a synchrony of motor, emotional, and interpersonal rhythms.
Autism spectrum disorder (ASD) – a developmental disorder char-
acterized by social communication impairments associated with
repetitive interests and behaviors – provides an interesting and
challenging model of abnormal melatonin production in early
developmental disorders and its possible relationship with autistic
behavioral impairments.
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This article proposes a central role of rhythmicity and syn-
chrony of rhythms in typical child development and offers a new
integrative approach, which considers autism as a disorder of bio-
logical and behavioral rhythms. In this perspective, promising
avenues will be discussed in this article for potential therapeu-
tic benefits in ASD of melatonin and developmental behavioral
interventions that emphasize rhythms and synchronization, such
as the Early Start Denver Model (ESDM).
PHYSIOLOGICAL AND BEHAVIORAL RHYTHM
DISTURBANCES IN AUTISM
AUTISM AS A DISORDER OF BIOLOGICAL RHYTHMS
Alterations in circadian sleep–wake rhythm have frequently been
reported in autism (4, 5). More specifically, reduced total sleep
and longer sleep latency as well as nocturnal and early morn-
ing awakenings are often observed in individuals with ASD (6–
12). Furthermore, prior studies on melatonin in autism have all
reported abnormalities in melatonin secretion (see Table 1). In
addition, abnormalities in cortisol circadian rhythm have also
been reported in autism [for a review, see Tordjman et al. (13)]. In
particular, significantly higher frequency of absence of circadian
variation in melatonin and cortisol levels was observed in indi-
viduals with autism compared to typically developing controls.
Golombek et al. (14) described the effects of circadian desyn-
chronization that can enhance susceptibility to certain disorders
(metabolic, immune, cognitive, and somatic disorders including
cancer). It is noteworthy that congenitally blind children with con-
sequently abnormal melatonin secretion and synchronization [the
production of pineal-derived melatonin depends on the light act-
ing through the retinohypothalamic tract (15)] very frequently
display autism [up to 42% (16)], whereas hearing impaired chil-
dren, including hearing loss, show autism less frequently [up to
10% (17)]. More specifically, abnormally low daytime and night-
time melatonin secretion was associated with an absence of mela-
tonin circadian variation in some individuals with autism (18, 19),
which in turn, given the role of synchronizer of melatonin, also
has consequences on the circadian rhythms network, including the
cortisol circadian rhythm (13, 20).
This blunted circadian rhythmicity with no or little variability
might be related to the difficulties in adapting to changes typ-
ically observed in individuals with autism. Thus, children with
autism who are confronted with physiological continuity due
to absent circadian rhythms may have difficulties adapting to
changes in either their external or their internal environment
(26). Indeed, as previously underlined, the circadian clocks net-
work, synchronized by melatonin and involving an internal system
of continuity/discontinuity, allows adaptation to environmental
changes.
Similarly, blunted circadian rhythmicity may explain the dif-
ficulty observed in many children with autism in adapting to
Table 1 | Studies of melatonin levels in individuals with autism.
Study Sample Study group Measured variable Results
Ritvo et al. (21) Urine Young adults with autism
(N =10)
Melatonin concentration Increased daytime values compared to typically developing
controls
Similar nighttime values compared to typically developing
controls
Nir et al. (22) Serum Young men with autism
(N =10)
Melatonin concentration Increased daytime values compared to typically developing
controls
Decreased nighttime values compared to typically developing
controls
Kulman
et al. (19)
Serum Children with autism
(N =14)
Melatonin concentration
(24-h circadian rhythm)
Decreased nighttime values compared to typically developing
controls
No circadian variation in 10/14 (71.4%) children with autism
Inverted rhythm in 4/14 (28.6%) children with autism
Tordjman
et al. (23)
Urine Children and adolescents
with autism (N =49)
6-Sulphatoxymelatonin
excretion rate (12-h collection)
Decreased nighttime values compared to typically developing
controls
Melke
et al. (24)
Plasma Adolescents and young
adults with autism (N =43)
Melatonin concentration Decreased daytime values compared to typically developing
controls
Mulder
et al. (25)
Urine Children and adolescents
with autism (N =20)
6-Sulphatoxymelatonin
excretion rate (24-h collection)
Trend to lower 24-h melatonin excretion rate in
hyperserotonemic compared to normoserotonemic individuals
with autism
Tordjman
et al. (18)
Urine Post-pubertal adolescents
and young adults with
autism (N =43)
6-Sulphatoxymelatonin
excretion rate (split 24-h
collection)
Decreased daytime values compared to typically developing
controls
Decreased nighttime values compared to typically developing
controls
No circadian variation in 10/43 (23.2%) individuals with autism
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changes in rhythms of their external and internal environment.
Thus, rapid rhythms of sensory stimuli in their external envi-
ronment (e.g., repeated visual stimuli provided by a stroboscopic
light) can provoke epileptic seizure in some individuals with
autism [approximately one-third of children with autism have
epilepsy (27)]. Interestingly, EEG changes tended to be corre-
lated with an abnormal rhythm of melatonin in young adults
with autism (22). Furthermore, some parents have reported that
their daughters with autism experience epileptic seizures toward
the 14th day of their menstrual cycle, which is when luteinizing
hormone (LH) levels peak (Tordjman, personal communication),
suggesting quite tentatively that individuals with autism may have
difficulties adapting to periodic hormonal changes in their inter-
nal environment. We can state the following hypothesis: a change
in rhythm associated with excessive environmental stimuli might
strongly increase arousal and lead to physiological stress which, for
some individuals with autism, can disturb the rhythmic activity of
a particular brain area, leading it to fall out of sync with the rest
of the brain and causing its population of neurons to fire (depo-
larization and occurrence of an epileptic seizure). This underlines
the importance of stable physiological rhythms.
Finally, significant relationships have been found between lower
nocturnal melatonin excretion and increased severity of autistic
social communication impairments, especially for verbal commu-
nication and social imitative play (18, 23). These findings are in
agreement with studies suggesting an association between reduced
melatonin production and language impairment (22, 28). Along
the same line, the systemic administration in the animal model of
Zebra Finch of a melatonin-1B receptor antagonist at the begin-
ning of the night shortens the song and motif length and affects the
song syllable lengths produced the next day (29). Reduced mela-
tonin activity might create timing problems in biological clocks
with physiological and psychological effects that might be, accord-
ing to Boucher’s model of autism (30) and Wimpory’s theory (31),
involved in autistic impairments, notably in autistic social commu-
nication impairments. It is noteworthy that deficiency in oxytocin
[oxytocin is considered a bonding hormone (32, 33)] has also been
reported in autism (34, 35) and bonding is involved in the devel-
opment of very early social interaction in infants. Interestingly, the
release of oxytocin by the posterior pituitary gland follows a robust
circadian rhythm in mammals. Further studies are needed to better
understand the underlying mechanisms of oxytocin anomalies in
autism and to explore, in particular, possible oxytocin rhythm dis-
turbances in ASD. The importance of the synchrony of rhythms
in the development of social interaction and communication is
detailed in the next section.
IMPORTANCE OF SYNCHRONY OF RHYTHMS FOR SOCIAL
COMMUNICATION IN TYPICAL DEVELOPMENT AND AUTISM
SPECTRUM DISORDER
Several studies, based on animal models and human perinatal
development, suggest that stable patterns of repeated stimuli in the
form of maternal physiological rhythms, involving cross-modal
perception such as regular cardiac rhythm, which provides the
fetus with auditory and vibratory stimuli, allow the fetus to inte-
grate sensory information facilitating prenatal perceptual learning
and develop a coherent representation of his or her internal and
external environment (36–38). Fluctuations in the physiological
rhythms (variants), such as variations in the maternal cardiac
rhythm and also variations in hormone levels involved in the cir-
cadian rhythms that are already present during the fetus life (the
fetus’ circadian rhythms are the mother’s ones), occurring in a
background of regular repetition of identical sequences (invari-
ants), may help the fetus to develop the ability to adapt to change
in an environment characterized by high regularity. As previously
emphasized (38), very early mother–infant relations provide a
secure environment based on the repetition of invariants, while
at the same time promoting adaptation to change through the
presence of variants. It is through the regular repetition of iden-
tical sequences of discontinuity, such as circadian rhythms, that
a continuum is constructed associated with the development of
adaptation to changes.
The development of the very earliest form of communication
relies on the sharing of emotions between mother and infant,
when, for example, the infant is suckling in his or her mother’s
arms, through emotional synchrony that enhances the integration
of sensory inputs (39, 40). Concerning memory processes, emo-
tions enable to “fix” events, just as a photographic fixing agent
sets images (38). Cortisol (a stress and arousal neurohormone)
crosses the placental barrier. The cortisol circadian rhythm, as well
as the melatonin circadian rhythm in the fetus and infant after
birth, are those of maternal cortisol and melatonin. Indeed, the
infant’s circadian cortisol and melatonin rhythms are only estab-
lished between 2 and 3 months of age in typical development, at
the same time that infants begin to have more regular sleep–wake
cycles associated with nighttime sleep lasting 6–8 h (41, 42). Inter-
estingly, this period coincides in typical development with the
emergence of social smiling by the second month of life (43), the
advent of mirror self-recognition at around 3 months of age (44),
and increased brain activation to speech occurring between 3 and
4 months of age (45).
At birth, the human immaturity of the cerebral cortex allows
initial learning to influence the neural architecture through
perceptual-action mapping (46, 47). The infant’s social skills, espe-
cially including imitation, shared attention, and empathic under-
standing, also contribute to the development of learning (46, 48).
Social synchrony can be defined as the dynamic and reciprocal
adaptation of the temporal structure of behaviors between inter-
active partners (49). In typically developing children, the quality of
social interaction depends on an active dialog between the parent
and the infant (50, 51). Numerous studies have been emphasizing
the importance of parent–infant synchrony and the construction
of shared timing in social communication development (52).
Also, biological markers were associated with relational syn-
chrony. First, oxytocin administration to parent enhances infant
physiological and behavioral readiness for social engagement and
parallels an oxytocin increase in infants (32). Second, neural cor-
relates were found using hyper-scanning recordings of EEG brain
activity and measures of neural synchronization between distant
brain regions of interacting individuals through a free imita-
tion task (53). Dumas and colleagues’ study (53) was the first to
record dual EEG activity in dyads of subjects during spontaneous
non-verbal interaction. Eleven same-sex pairs were scanned. They
found that interpersonal rhythmic oscillations were correlated
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with the emergence of synchronization in the brain’s alpha–mu
band between the right centro-parietal regions (an area involved
in social interaction) of both participants. Developmental psy-
chologists now study interaction not only as the addition of two
behaviors but also as a global phenomenon in which synchrony is
considered as social per se. To describe the dialog between two part-
ners engaged in behavioral and affective exchange, developmental
psychologists more and more take into consideration rhythm and
temporal course of both behavior and affect, regarded as key
expressions of adaptation during interaction (49, 52).
Only a few studies have addressed the importance of infant–
caregiver synchrony/reciprocity in the development of social com-
munication involving infants who subsequently are diagnosed
with autism. It appears appropriate in the field of autism to con-
sider the combined domain of social communication, as the most
recent version of the ADOS scale does, as well as the recently
released DSM-5 American classification. Methods to investigate
this issue include studies using early home videos (54), parental
interviews focusing on early abnormalities (55), and prospective
assessment of children at risk of ASD (e.g., siblings) (56, 57). Stud-
ies have revealed a pervasive developmental course in infants who
were later diagnosed with ASD. Thus, the first signs were abnor-
malities in eye contact, imitation, disengagement, joint attention,
orienting to name, and body language. These behaviors are parts
of the affective tuning disturbances; the term affective tuning,
defined by Stern (58) as the “execution of behaviors expressing the
emotional ownership of a shared affective state,” refers to infant–
caregiver emotional communication based on rhythmic similarity
from the second semester of life onward. Also, these behaviors
are important precursors of later-developing symptoms. However,
whether these first signs impair early infant–parent interactions
and whether they reflect already autistic behavioral impairments
in the infant remain to be explored. In two related studies based
on home movies of children later diagnosed with autism, Saint-
Georges et al. (54) and Cohen et al. (59) showed that motor and
emotional asynchrony was present between infants and parents
before 12 months of age, and parents perceived weaker initia-
tives from their children. In addition, parents experienced weaker
interactive responsiveness from their children and increasingly
tried to compensate this perceived deficit by soliciting behav-
iors through touching the infant. This was particularly observed
after 12 months of age for the fathers of infants who were later
diagnosed with autism.
Many authors have studied imitation in children with autism
(imitation of other people’s faces, gestures, or vocal signals) in
order to better understand the development of autistic social com-
munication impairments. This specific type of imitation is referred
to as “spatial” imitation to highlight the capacity to produce an
instantaneous copy of the form of the signal. However, another
way to communicate with others is to perform a “temporal” imi-
tation of their behavior (60). This is what humans do through
rhythmic finger or foot taping, dancing, singing, and drumming
in synchrony with others (61). Xavier et al. (62) highlighted the
importance of rhythmicity and synchrony in the development
of children’s imitative exchanges with peers. From birth, a child
has a predisposition to engage, intersubjectively, with the rhytmic
actions and awareness of other persons, and to move in synchrony
with them (44, 63). Synchronic imitation is an important preverbal
way to communicate among peers (64, 65). This reciprocal expe-
rience concerns two children able and motivated to coordinate
their behavior with the non-ritualized behavior of the other, in
both form and timing and to alternate turns between model and
imitator (66). The impression of fluidity in the coordination of
movements between partners is underlined by mutual attention,
engagement, continuous adaptation, and turn taking (67). This
rhythmic process made of ludic spontaneous imitation reveals
moments of discontinuity occurring in a background of conti-
nuity. Neural bases of this coupling activity are constituted by
the neuron mirrors system (68), with the same evidence show-
ing that the neuronal structures involved when a mental state is
experienced, are also recruited during the observation of others.
Guionnet et al. (69) designed a free imitation paradigm in an
fMRI study to examine some neural correlates of social interac-
tion. Their results agree with those previously evidenced (70, 71)
concerning the core circuit of imitation, but they found different
activations between the situation of imitating and that of being
imitated.
A special quality of temporal imitation is the ability to use dif-
ferent motor movements in order to communicate. Thus, simple
finger tapping can be synchronized with another’s head nodding
or trunk movements, whether entrained by one of the movements
or in response to external synchronizing stimuli such as music.
Although animals and humans can perceive rhythms and produce
rhythmic motor patterns, only humans can adapt their rhyth-
mic movements to external rhythms (72) [with the exception of
the cockatoo (73)]. The ability to be rhythmically synchronized
with the environment appears important for infant development
in the emotional, cognitive, social, and sensorimotor realms (44,
74). It has been demonstrated that the human fetus and newborn
already have the capacity to perceive and produce rhythms (75).
The ability to produce temporally adapted motor patterns comes
later and depends on the specific motor system involved and the
relationship between the beat presented and the spontaneously
occurring motor tempo of the infant (76, 77). It should be fruitful
to longitudinally examine children with autism in terms of abil-
ity to adapt their own rhythm to external rhythms. Interestingly,
clinical observations suggest that some children with autism are
able to respond to an external rhythmic vocalization by a sim-
ilar rhythmic motor pattern such as hand flapping (Tordjman,
personal communication). However, previous studies reported
disorganized rhythms, stereotypies, and poor synchrony in most
of these children (78), which might be related to the low mela-
tonin levels reported to be associated in autism with the severity
of verbal communication and social imitative play impairments
(18, 23). Melatonin, as a regulator of physiological rhythms and
oscillations, might enhance the capacity of children with ASD to
synchronize their movements with movements of others (this syn-
chronization of movements is needed for imitative play) and with
external rhythmic auditory stimuli (such as music and/or human
voice enhancing their verbal skills). Interestingly, in a study of
social smiling in infants (79), there was no difference in frequency
of smiling between 2- and 5-month-old infants with and without
ASD during infant–caregiver face-to-face interactions. However,
whereas typically developing infants showed a significant increase
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in smiling rate when caregivers were smiling, smiling in infants
later diagnosed with ASD was not synchronized with smiling
in caregivers and was not contingent upon caregiver behavior
(caregiver facial expressions and vocalizations). Furthermore, it
is noteworthy that, as previously indicated in this section, the
infant’s melatonin circadian rhythm is established between 2 and
3 months of age, and a study (80) reported that eye contact was
normal in 2-month-old infants later diagnosed with autism but
declined between 2 and 6 months of age, suggesting an additional
argument in favor of a possible relationship between the well-
replicated nocturnal melatonin deficit in autism (see Table 1) and
the development of autistic social communication impairments.
REPETITIVE BEHAVIORS AND INTERESTS
Repetitive behaviors and interests are defined, according to DSM-
5 criteria (81), as a repetition of identical sequences of behaviors
for motor stereotypies (motor stereotypies involve repetitive mal-
adaptive movements) or thoughts for restrictive patterns of inter-
ests (restrictive and repetitive interests involve fixated interests,
adherence to routines, or ritualized and rigid thinking patterns).
Thus, repetitive behaviors and interests can be viewed as behavioral
responses to the need to create discontinuity that is repeated at
regular intervals, which could have been fundamentally lacking in
the physiological development of children with autism due to the
melatonin deficit reported in autism. Our finding (18) observed
in a sample of 43 adolescents and young adults with autism (noc-
turnal excretion of 6-SM was significantly negatively correlated
with repetitive use of objects), taken together with improvement of
stereotyped behaviors following administration of melatonin in 24
children and adolescents with ASD (82), supports this hypothesis.
The autistic deficit in melatonin secretion might lead to physio-
logical rhythm disturbances in autism impairing biological circa-
dian rhythms and even, in certain cases, to an “endless” physiolog-
ical continuity provoked by the absence of variation in melatonin
levels. From this perspective, stereotyped behaviors and interests
can be seen as offering to children with autism rhythmic forms
providing rhythmicity and discontinuity through the creation of
repeated identical patterns. Albert Goldbeter (83), director of the
Chronobiology Unit at the Brussels Sciences University, underlines
that life is rhythm. It is noteworthy that the word pineal comes
from pine cone that is a Mesopotamian symbol representing the
source of life and the power of regeneration. In Asia, the pineal
gland is considered as the 7th chakra and represents the location
of the soul and the highest level of consciousness.
Donald Winnicott (84) emphasized that “the main problem
for a typically developing child is to be able to create a con-
tinuum out of discontinuity.” According to him, the first opti-
mal container (“holding environment”) for the newborn is the
progressive internalization of the rhythmic structures of feeding
(rhythmic ebb and flow corresponding to the kinesthetic experi-
ence of suckling), providing a sense of continuing existence. We
can nevertheless hypothesize, as we did in the previous section
and in a prior article (26), that this internalization process starts
far earlier, in the womb, through maternal physiological rhythms;
conversely, based on clinical observations in autism, children with
autism create discontinuity out of continuity. We can also state the
hypothesis that children with autism, confronted with an“endless”
physiological continuity (or at least with an absence of physiolog-
ical discontinuities repeated at regular intervals), would develop
anxiety and stress due to the lack of secure stable rhythms, and
would therefore try to create by themselves rhythmicity in order
to control them through stereotyped behaviors. However, the rela-
tionships between stereotyped behaviors and stress responses or
anxiety need to be clarified given discrepant results reported in
some studies (85, 86).
Finally, it should be noted that several studies have also recently
opened new behavioral, neurobiological, and pharmacological
perspectives on autistic repetitive behaviors, especially on self-
injurious behaviors [for a review, see Adler et al. (87), Minshawi
et al. (88), and Stigler (89)]. Thus, research on potential therapeu-
tic effects for repetitive behaviors and interests should investigate
benefits of melatonin in ASD (see next section) but should not be
limited to the administration of melatonin.
THERAPEUTIC BENEFITS OF MELATONIN IN AUTISM
SPECTRUM DISORDER
Published melatonin treatment studies in autism are presented in
Table 2. Many have been most concerned with effects of melatonin
on sleep. Reviews, commentaries, and meta analyses of melatonin
treatment studies are presented in Table 3. These two tables come
from a prior article of our team (26).
As previously discussed (26), the treatment studies have a
number of limitations. In some studies individuals covering a
wide age range were included with pre-pubertal, pubertal, and
post-pubertal individuals being studied (102, 103, 105). Reported
differences in pineal melatonin secretion according to age and
pubertal stage, coupled with the clearly developmental nature of
autism, suggests that therapeutic effects of melatonin might vary
considerably with age and pubertal status (23). Studies have also
been limited by small sample sizes (90–93, 95, 96, 98, 102, 104).
In larger studies, heterogeneous groups are often examined and
have included blind individuals and individuals with various neu-
rological disabilities with concomitant intellectual disability. In
such studies, often results seen for the autism subgroup are not
separately presented (97, 100, 103–107). The specificity and inter-
pretation of the results with respect to autism are often unclear.
Additional research is needed to determine whether and which
findings might be specific to autism or whether melatonin’s effect
might be similar across groups. It can be hypothesized that mela-
tonin’s effects are due to actions on certain behavioral dimensions
and that they can be observed across disorders. However, it should
be pointed out that in our studies (18, 23), lower melatonin
excretion was significantly associated with social communication
impairments rather than with sleep problems. Future studies of
melatonin in ASD should simultaneously examine melatonin lev-
els, sleep problems, autistic behavioral impairments, and level of
functioning so that a more complete picture can emerge.
It is worth noting that just a few of the therapeutic trials of
melatonin have assessed effects on autistic behavioral impair-
ments. These include reports of improved communication (105),
reduced social withdrawal (82, 99), decreased stereotyped behav-
iors and rigidity (82, 102), and reduced anxiety (99, 103). Fur-
thermore, at time the improvements noted were not sufficiently
detailed. For example, Wright et al. (105) reported significant
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Table 2 | Studies on potential therapeutic benefits of melatonin in autism.
Study Journal Population Design Duration of
treatment
Melatonin
(formulation,
dose)
Time of
intake
Main outcome
measures
Effects on sleep Other outcomes Comments
SINGLE CASE REPORTS
Horrigan
and
Barnhill
(90)
J Am Acad
Child
Adolesc
Psychiatry
17-year-old boy with
Asperger’s Syndrome (AS)
– Not given 3 mg 20–30 min
before
bedtime (BB)
Sleep Sleep improvement. No
side effects
Daytime behavior
improvement
–
Hayashi
(91)
Psychiatry
Clin
Neurosci
14-year-old boy with
autistic disorder, severe
intellectual disability and
phase delay with
polyphasic sleep
– 4 months Immediate release
(IR) 6 mg
11:00 p.m. Sleep Melatonin increased sleep
duration. No side effects
None –
Jan et al.
(92)
Dev Med
Child Neurol
12-year-old boy with AS
and complex sleep
disturbance (phase delay
and parasomnias)
– 6 months Controlled release
(CR) 5 mg
30 min BB Sleep Normalization of the
sleep–wake rhythm and
disappearance of
parasomnias. No side
effects
None –
RETROSPECTIVE STUDIES
Gupta and
Hutchins
(93)
Arch Dis
Child
9 cases of children with
autistic disorder (AD)
aged from 2 to 11 years.
Chronic sleep problems
Not given 1 week to
1 year
IR 2.5–5 mg 45 min BB Parental evaluation of
sleep
56% showed
improvement in total
sleep duration
None No standardized collection
of sleep variables
Andersen
et al. (94)
J Child
Neurol
107 children and
adolescents aged from 2
to 18 years with ASD
(DSM-IV): 71% AD, 5%
AS, 19% PDDNOS
(pervasive developmental
disorder not otherwise
specified)
Not given Mean
duration:
1.8 years
IR in 91% of the
cases. Dose
escalation protocol
from 1 to 6 mg
based upon age
30–60
min BB
Parental evaluation of
sleep
Parents reported full
(25%) or partial (60%)
improvement. Beneficial
effects of melatonin seem
to stop after 3–12 months
despite the use of higher
doses. Side effects
observed in 3 children:
sleepiness, fogginess,
increased enuresis
None No standardized collection
of sleep variables. The
loss of response to
melatonin treatment is
discussed in the text
Galli-
Carminatti
et al. (95)
Swiss Med
Wkly
6 adult patients with AD
(CIM-10) and intellectual
disability, aged from 19 to
52 years
Not given 6 months IR. Dose escalation
protocol from 3 to
9 mg if clinically
required
45 min BB Sleep (CGI-S and
CGI-I)
Improvement in sleep
onset latency, night and
early morning
awakenings. No side
effects
None No standardized collection
of sleep variables. Two to
four associated
psychotropic drugs per
patient
OPEN-LABELTRIALS
Jan et al.
(96)
Dev Med
Child Neurol
15 children with multiple
neurological disabilities
and severe sleep
disorders
Not given Not given 2–10 mg Bedtime Not given Partial improvement in
sleep disorders. No side
effects
Behavior and social
improvement
Heterogeneous sleep
disorders and neurological
disabilities
Ishizaki
et al. (97)
NoTo
Hattatsu
50 children and young
adults with autism
(n=27) or mental
retardation (n=20) or
severe motor/intellectual
disability (n=3) aged
from 3 to 28 years with
sleep disorders
Not given Not given Not given Not given Sleep disorders and
emotional/behavior
disturbances
34 patients experienced
improvement in response
to melatonin. Side effects
reported in 17 patients
Improvements in
excitability when sleep
also improved. No change
in contrariness,
stereotyped behavior and
in school/workshop
refusal
Various types of insomnia
and diagnoses
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Melatonin
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Effects on sleep Other outcomes Comments
Paavonen
et al. (98)
J Child
Adolesc
Psychophar-
macol
15 children with AS
(DSM-IV) aged from 6 to
17 years with severe
sleep problems for at
least 3 months
Not given 14 days IR 3 mg 30 min BB Sleep (72 h-period
actigraphy, sleep
diaries), daytime
behavior (Karolina
Sleepiness Scale;
KSS), Child Behavior
Checklist (CBCL)
Melatonin treatment was
associated with significant
decrease in sleep onset
latency and nocturnal
activity. Discontinuation of
melatonin led to a
significant decrease in
sleep duration and more
nocturnal activity. Side
effects in 20% of the
cases: tiredness,
headaches, severe
sleepiness, dizziness,
diarrhea
Significant improvement
of daytime behavior
(CBCL)
No principal outcome
specified. KSS is not
validated in children nor
in ASD
Giannotti
et al. (99)
J Autism
Dev Disord
29 children with AD
(DSM-IV) aged from 2 to
9 years with current sleep
problems
Controlled-release
melatonin
6 months Dose escalation
protocol from 3 mg
(1 mg of IR+2 mg
of CR) to 6 mg when
clinically required,
based upon age
(max 4 mg under
4 years old and max
6 mg over 6 years
old)
08:00 p.m. Sleep (diaries and
Children’s Sleep
Habits Questionnaire
CSHQ), daytime
behavior, Childhood
Autism Rating Scale
(CARS)
Melatonin treatment was
associated with
improvement in sleep
onset latency, night
awakenings, and sleep
duration, which vanished
after melatonin
discontinuation. No side
effects
Parents reported less
irritability, less anxiety,
and better mood.
Significant improvement
of depression, anxiety,
and withdrawal symptoms
during melatonin
treatment in children with
AS. No effect was
reported on the CARS
No principal outcome
specified. Missing data:
analyses on 25 patients
De
Leersnyder
et al. (100)
Pediatr
Neurol
88 children with
heterogeneous
neurodevelopmental
disorders (Smith-Magenis
syndrome, mental
retardation,
encephalopathy,
Angelman syndrome, Rett
syndrome, Bourneville
syndrome, blindness, and
autism) aged from 5 to
20 years. Seven patients
with autism, mean age
12 years old
6 years of open-label
follow up
3 months CR 2–4 mg (<40 kg)
or 6 mg (>40 kg)
based upon weight
60 min BB Parental evaluation of
sleep and mood
(self-constructed
questionnaire)
According to parental
reports, both sleep
latency and sleep duration
improved within 3 months
such as night awakenings,
sleep quality, and daytime
napping. Eleven children
experienced adverse
events (daytime nap,
difficulties in swallowing
tablets) that the parents
attributed to melatonin
treatment
12% of the parents
reported improvements of
mood in their children
Heterogeneous
neurodevelopmental
disorders. Results cannot
apply to a population with
autism spectrum
disorders. No
standardized collection of
sleep and mood
parameters. Mean dose
for patients with autism:
5.7 mg
Malow
et al. (82)
J Autism
Dev Disord
24 children with ASD
(DSM-IV, ADOS): AD, AS,
and PDDNOS aged from 3
to 9 years. Sleep onset
delay of 30 min or longer
confirmed on actigraphy.
Exclusion of
neurodevelopmental
disabilities such as fragile
X, Down, and Rett
syndromes
Before treatment
families received
structured sleep
education and
children underwent
a treatment
acclimatation phase
in order to be sure
the melatonin will
be taken
14 weeks CR. Dose escalation
protocol from 2 to
9 mg when clinically
required
30 min BB Sleep (actigraphy,
Children’s Sleep
Habits Questionnaire;
CSHQ, diaries),
daytime behavior
(Child Behavior
Checklist; CBCL,
Repetitive Behavior
Scale-Revised),
parental stress
(Parenting Stress
Index Short Form),
side effects (Hague
Side Effects Scale)
Significant improvement
in sleep latency within the
first week of treatment
but not for other sleep
parameters such as night
awakenings and sleep
quality
Significant improvement
in children’s behavior
(withdrawal, affective
problems, attention-deficit
hyperactivity,
stereotyped, and
compulsive behaviors).
Significant improvement
in parental stress
No placebo
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PLACEBO-CONTROLLEDTRIAL
McArthur
and
Budden
(101)
Dev Med
Child Neurol
9 children and
adolescents with Rett
syndrome aged from 4
to 17 years. Mean
age:10 years old
Randomized
double-blind
crossover trial
2 periods
of 4 weeks
with a
wash out
period of
1 week
2.5–7.5 mg based on
weight
60 min BB Sleep (actigraphy,
diaries)
Significant improvement
in total sleep time. No
side effects
None –
Garstang
and Wallis
(102)
Child Care
Health Dev
11 children and
adolescents with ASD
aged from 5 to 15 years
with chronic sleep
disorders resistant to
behavioral treatment
Randomized
double-blind
crossover trial
2 periods
of 4 weeks
with a
wash out
period of
1 week
IR 5 mg 60 min BB Sleep (diary) Melatonin and placebo
were associated with
significantly decreased
sleep latency and
nocturnal awakenings,
increased total sleep
time. No side effects
Several parents and class
teachers commented that
their children were easier
to manage and less rigid
in their behavior while
taking melatonin
ASD criteria were not
consensual. Only 7
children completed the
trial. Investigators found
that some of the placebo
capsules were empty.
Missing data
Wasdell
et al. (103)
J Pineal Res 51 children and
adolescents with
neurodevelopmental
disabilities (16 patients
with ASD) aged from 2 to
18 years. Sleep delay
phase syndrome and
impaired sleep
maintenance with
resistant to sleep hygiene
intervention
Randomized
double-blind
crossover trial. Three
weeks trial followed
by a 3-month
open-label study.
Behavioral sleep
treatment before
inclusion
2 periods
of 10 days
with a
wash out
period of
3–5 days
Dose escalation
protocol based on
unspecified
conditions: from
5 mg (1 mg
FR+4 mg CR) to
15 mg
20–30
min BB
Sleep (actigraphy,
diaries, CGI-S, CGI-I),
familial stress (family
stress scale)
Significant improvement
in total sleep duration and
sleep latency as well as
reduced stress levels in
parents in the melatonin
arm
Half of the patients with
ASD had their dose
increased during the
open-label phase with no
additional improvement in
sleep latency or sleep
duration, but caregivers
reported less anxiety
Unspecified ASD criteria.
Fifty patients completed
the trial and 47 completed
the open-label phase.
Selection bias due to
previous melatonin
treatment (25% of the
cases). At the end of the
trial, 29 patients received
a dose of 10 or 15 mg.
Higher doses were
necessary in patients with
bilateral cerebral lesions
Wirojanan
et al. (104)
J Clin Sleep
Med
12 children and
adolescents with
unspecified sleep
problems, aged from 2 to
15 years: 5 patients with
AD (ADOS and ADI-R),
3 patients with fragile X
syndrome with AD,
3 patients with AD and
fragile X syndrome, and
1 patient with fragile X
premutation
Randomized
double-blind
crossover trial
2 periods
of 2 weeks.
No wash
out period
IR 3 mg 30 min BB Sleep (actigraphy,
diary)
Significant, but mild
improvement in total
sleep time (+21 min) and
decrease in sleep latency
(−28 min)
None Missing data: only 12
patients completed the
trial (order bias). No
subgroup analysis in AD
patients. No side effects
Wright
et al. (105)
J Autism
Dev Disord
22 children and
adolescents aged from 3
to 16 years with ASD
(ICD-10, ADOS, ADI-R):
AD (70%), AS (10%), and
AA (20%). No fragile X or
Rett syndrome. Current
sleeplessness (confirmed
on a 1-month-diary) and
resistant to behavioral
treatment
Randomized
double-blind
crossover trial
2 periods
of 3 months
separated
by 1 month
of washout
IR. Dose escalation
protocol from 2 to
10 mg when
clinically required
30–40
min BB
Sleep (sleep
difficulties
questionnaire, diary),
daytime behavior
(Developmental
Behavior Checklist),
side effect
questionnaire
Significant improvement
in sleep latency (−47 min)
and total sleep duration
(+52 min) in the melatonin
arm. No improvement in
night awakenings. The
side effect profile was not
significantly different
between the 2 groups
Improvement in children’s
behavior in the melatonin
arm that was significant
for communication
(p=0.045)
Missing data. Analysis on
16 patients. No
actigraphy. Mean
melatonin dose: 7 mg
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r communication improvement without reporting separate verbal
or non-verbal scores. In other instances, investigators did not use
validated instruments; thus, Garstang and Wallis (102) reported
improvements in rigidity based solely on parents’ and teachers’
comments, while Wasdell et al. (103) reported reductions in anx-
iety based on caregivers’ comments. All of the published clinical
trials of melatonin in autism/ASD have used sleep measures as
their main outcome variable and none have studied the dose–
response relationship for melatonin. To reiterate, there is a real
need for further studies on the therapeutic effects of melatonin
that are conducted on large, relatively homogeneous samples and
that employ validated behavioral assessments.
SYNCHRONIZATION OF MOTOR, EMOTIONAL, AND
RELATIONAL RHYTHMS: THERAPEUTIC BENEFITS OF THE
EARLY START DENVER MODEL IN AUTISM SPECTRUM
DISORDER
Although there is a growing interest in the role of motor, emo-
tional, and interpersonal rhythms in autism, there have been only
a few attempts to focus on behavioral synchronization of social
communication during therapeutic and educational intervention
in autism. The ESDM, developed by Sally Rogers and Geraldine
Dawson (119, 120), is a comprehensive behavioral and devel-
opmental early intervention approach designed for delivery to
12- to 60-month-old children. The model uses the knowledge
of how typical infants, toddlers, and pre-schoolers develop, in
addition to knowledge of the ways in which autism affects early
development, in order to facilitate an appropriate developmental
trajectory in young children with autism beginning at the ear-
liest ages. The goals of the ESDM are to reduce the severity of
disabling autism symptoms in very young children, and to accel-
erate children’s developmental rates in a multitude of domains,
including cognitive, social–emotional, and language domains. In
order to do so, there is a strong focus on interpersonal engage-
ment marked by synchrony and reciprocity during teaching, as
research demonstrates that these are closely tied to successful
developmental outcomes (121–124). Within the ESDM, the ther-
apist and child work together to develop and sustain coordinated,
synchronous activity routines into which teaching opportunities
are embedded. The ESDM reflects an understanding of the impor-
tance of synchrony of motor, emotional, and relational rhythms
for the early development of young children with autism.
Thus, the ESDM allows one to initiate interaction with the
child by synchronizing the therapist’s motor, emotional, and
relational rhythms with the child’s rhythms (providing invari-
ants/continuity). For example, if the child uses an object with a
rhythmic motor pattern, the therapist will reproduce this behav-
ior with exactly the same rhythmic pattern. The evolution of the
child is then facilitated by introducing new and different rhythms
(providing variants/discontinuity). In addition, the adjustment of
the therapist’s behaviors, movements, level of arousal, and pos-
ture (for example, standing up, lying down, or sitting) to those of
the child contributes to foundational invariants necessary during
the initial phase. Furthermore, the ESDM requires the program to
be implemented in different environments (such as home, school,
and caregiver settings), which also contributes to the introduction
of variants.
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Table 3 | Review, meta-analysis, and discussion of therapeutic uses of melatonin in autism.
REVIEW/META-ANALYSIS
Jan and
O’Donnel (108)
J Pineal Res Review based on100 individuals with chronic sleep disorders, aged from 3 months to 21 years. Half of these
100 patients presented visual impairment or blindness. Melatonin dose ranged from 2.5 to 10 mg. Higher doses
were needed in patients with impaired sleep maintenance. Partial or total improvement in sleep parameters
was found in 82% of the cases. No side effects
Jan et al. (109) Dev Med Child
Neurol
Systematic review of studies on melatonin in children. Twenty-four studies found, most of them were case
reports or uncontrolled studies with small samples. Mean age: 10 years old. Associated diagnosis: blindness
and neurodevelopmental disabilities, 1 single case of an adolescent with AS (76). Doses ranged from 0.5 to
20 mg. Improvement in sleep in all the studies
Phillips and
Appleton (110)
Dev Med Child
Neurol
Only three studies, reporting a total of 35 children, fulfilled the criteria for inclusion (randomized controlled
clinical trials). Two of them reported a significant decrease in time to sleep onset
Braam et al. (111) Dev Med Child
Neurol
Meta-analysis of placebo-controlled randomized trials of melatonin in individuals with intellectual disabilities and
sleep problems. Nine studies were included. Various doses and formulations of melatonin were given. Melatonin
decreased sleep latency by a mean of 34 min (p<0.001), significantly decreased mean number of wakes per
night (p=0.024), and increased total sleep time by 50 min (p<0.001). Specified reports on adverse effects
were given in four studies. Adverse effects were minor and their incidence in both melatonin and placebo
phases were the same. Patient groups in studies included in this meta-analysis were very heterogeneous
Guénolé
et al. (112)
Sleep Med Rev Systematic review of efficacy and safety of exogenous melatonin for treating disordered sleep in individuals
with autism spectrum disorders: 4 case reports, 3 retrospective studies, 2 open-label clinical trials, 3
placebo-controlled trials. All studies supported the existence of a beneficial effect of melatonin on sleep in
individuals with ASD with minor side effects. Limitations are: small sample, clinical heterogeneity of ASD and
sleep disorders, varying methods used to measure sleep, confounding factors such as behavioral interventions
and cross over design (no analysis of intention to treat). Melatonin doses ranged from 0.75 to 10 mg/day. The
authors propose that future research on the efficacy of melatonin in children with ASD should include daytime
functioning as a principal outcome measure. Only 6 patients of 205 presented side effects: daytime sleepiness,
fogginess, dizziness, nocturnal enuresis, tiredness, headache, and diarrhea
Doyen et al. (113) Eur Child Adolesc
Psychiatry
Systematic review on pharmacokinetics data on melatonin and its role in sleep disorders and autism spectrum
disorders. Authors reviewed 17 studies on effectiveness and side effects of melatonin in patients with AD, AS,
PDDNOS, and Rett syndrome. Effectiveness on sleep disorders was found in all the studies, side effects were
reported in 5 studies. Melatonin doses ranged from 0.5 to 10 mg. Melatonin seems to have anxiolytic
properties. Most frequent reported side effects: infections, flu, epilepsy, intestinal disorders, and agitation
Rossignol and
Frye (114)
Dev Med Child
Neurol
Aim of the study: investigate melatonin-related findings in ASD including AD, AS, Rett syndrome, and PDDNOS.
Eighteen studies on melatonin treatment on ASD patients were identified (5 RCT), 12 of them reported
improvement in sleep with melatonin in 67% to 100% of the patients. Six studies reported improvement in
daytime behavior (less behavioral rigidity, ease of management for parents and teachers, better social
interaction, fewer temper tantrums, less irritability, more playfulness, better academic performance, and
increased alertness). Melatonin doses ranged from 0.75 to 15 mg, age of patients ranged from 2 to 18 years,
treatment duration ranged from 2 weeks to 4 years. Twelve studies explored side effects (headache, tiredness,
dizziness, and diarrhea) in which 7 studies reported no side effects. Nine studies found low levels or abnormal
circadian rhythm of melatonin in ASD. A correlation between these abnormal levels and autistic behaviors was
found in 4 studies. Night time urinary excretion of melatonin metabolite (6-SM) was reported to be inversely
correlated with the severity of impairments in verbal communication, play, and daytime sleepiness in patients
with ASD. Five studies found genetic abnormalities of melatonin receptor and enzymes involved in melatonin
synthesis
Reading (115) Child Care Health
Dev
Correlation between plasmatic levels of melatonin and autistic behaviors was found. Melatonin groups showed
improvements in total sleep duration and sleep onset latency versus placebo groups but not on night
awakenings
(Continued)
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Table 3 | Continued
LETTERTOTHE EDITOR
Guénolé and
Baleyte (116)
Dev Med Child
Neurol
Response to the Rossignol and Frye review (73); Authors proposed that studies should separately explore sleep
disorders in patients with ASD and sleep disorders in patients with Rett syndrome
Guénolé and
Baleyte (117)
Pediatr Neurol Response to the De Leersnyder et al. study (86) of open-label trial. The definition of «chronic sleep disorder»did
not refer to international classifications. Half of the children manifested Smith-Magenis syndrome that involves
specific abnormalities of melatonin secretion.Thus, results cannot apply to a population with ASD.The effects of
melatonin should be studied separately in each neurodevelopmental disorder and with specific sleep diagnoses
DISCUSSION/COMMENTARY
Jan and
Freeman (92)
Dev Med Child
Neurol
Discussion on melatonin use in children with ADHD, ASD, neurodevelopmental disabilities, epilepsy, and
blindness. Exogenous melatonin seems to regulate endogenous melatonin secretion. It seems to be more
effective in sleep–wake cycle disorders with sleep onset delay disorders. Night and morning awakenings seem
to be more difficult to treat, such as sleep problems associated with cerebral lesions. The more the child shows
mental or motor comorbidities, the more the melatonin dose is high
Lord (118) J Autism Dev
Disord
General brief discussion of melatonin and its potential for treating sleep problems in autism
The ESDM is both a curriculum and a set of teaching prac-
tices. A specific developmental curriculum, administered every
3 months in typical practice, defines the skills to be taught at any
given time. In addition, a manual of teaching practices outlines
the ways in which these skills are to be taught. Embedded within
both the curriculum and the set of teaching practices is a focus
on rhythms and synchrony. In other words, when therapists are
working within the model, a focus on rhythms permeates both
what they teach and how they teach it.
The ESDM curriculum outlines skills to be taught in mul-
tiple areas, including cognitive, social–emotional, and language
domains. The curriculum focuses heavily upon the teaching of
skills that promote engagement with other people in a synchro-
nous, rhythmic way. Many young children with autism enter an
ESDM program with weaknesses in these skills, such as imitation,
joint attention, orienting to name, and eye contact, and these
have broad influences upon the manner in which these chil-
dren can engage with others. It is well recognized that learning
occurs within a social context and that social skills, such as imita-
tion and shared attention, provide a foundation for many aspects
of learning, including language, cognitive, and social–emotional
abilities. Thus, the ESDM focuses heavily on the development of
social engagement and interactional synchrony early on in order
to further support learning of a wide range of skills.
One area of focus within the ESDM, which is closely tied to the
concept of rhythmicity, is imitation. Young children with autism
often exhibit deficits in their imitation skills, including those of
imitating others’ facial expressions and movements, gestures, body
actions, and actions on objects. From the beginning of a young
child’s ESDM program, teaching of imitation is stressed, from
basic imitation of actions on objects to more nuanced imitation
of sound effects produced in play. Spontaneous and appropriate
imitation of others is typically rhythmic and marked by mutual
attention, continuous adaptation, and turn taking. The beginning
stages of facilitating imitation and social engagement often start
with imitating the child, thereby entering into a rhythmic inter-
action with the child. By imitating the child’s movements and
establishing a synchronous interaction, eye contact and mutual
engagement in the interaction are promoted (125).
Rhythmicity is also involved in the way teaching occurs within
the ESDM upon multiple levels, from the basic structure of each
interactive routine to the ways in which adults engage with chil-
dren during interaction. Social communication is about sharing
moments of synchrony with others, and the ESDM supports the
emergence of interactional synchrony. The therapist facilitates the
occurrence of synchronous moments and strings them together
into routines into which the therapist can naturally embed teach-
ing opportunities. The primary vehicle through which all teaching
is accomplished in this model is the joint activity routine, which
is permeated by moments of rhythmic, synchronous interaction,
and enriched with positive affect. Adult and child are attuned to
one another, both taking the lead, both following the other’s lead,
taking turns, and creating a positive and motivating activity in
conjunction with one another.
The joint activity routine, although flexible and naturalistic,
adheres to a four-part structure: (1) opening, (2) theme, (3) elabo-
ration, and (4) closing. This structure provides a set of invariants,
against which multiple variants can occur at differing levels. In
order to begin engagement within a joint activity routine, the adult
works hard to find the child’s smile. This can often be accomplished
by getting into the child’s own rhythm (imitating a child’s actions
is a very powerful tool to facilitate motivated response and inter-
action) or by finding a rhythm that the child likes. For example,
perhaps a child finds a toy drum and begins banging on it with his
hand. In the ESDM, the therapist would join the child and would
likely take her/his own drum and imitate the child’s actions, join-
ing his rhythm. This would be considered the opening phase of
the joint activity routine.
Next, the child and adult would develop a theme. This can be
considered a continuation of the rhythm introduced during the
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opening phase – in our example, banging a drum slowly with
hands. The adult and child would take turns doing so, each lead-
ing and each following. The skillful adult would embed teaching
opportunities into these turns – perhaps a focus on eye contact
during dyadic engagement, or on imitation of actions on objects,
or on giving and taking objects with eye contact. Both partners
then play within this rhythm for a while, until one introduces a
variant, or elaboration. In the ESDM, elaboration occurs by intro-
ducing a change into the joint activity routine, a change in the
rhythm which often allows different teaching targets to be prac-
ticed. In this example, the child and adult might start to play
peek-a-boo behind the drums. A new rhythm would need to be
established, and both partners would work together in order to
do so. An elaboration of this sort is a rhythmic fluctuation occur-
ring against a background of invariants (e.g., the same interactive
partner, the same material, the same setting), which allows the
child to learn to adapt to change and teaches the child how to
engage with people and materials differently. Finally, this rhythm
would likely begin to fade, the teaching value of the activity would
start to diminish, and/or the child would begin to lose motivation.
The fourth stage of the joint activity routine – the closing – is
the last part of the joint activity routine. Adult and child might
help one another clean up the materials, and then both partners
would begin an entirely new joint activity routine. This could often
involve a change in location, activity level, or teaching domain,
and an entirely new set of coordinated interactions would be
developed.
Within the joint activity routine, synchrony pervades within
several different levels and in several different areas. Adult and
child are attuned to one another and responsive to one another in
terms of sensory input and output, motor actions, and emotions.
Coordinated dyadic engagement, well-balanced in terms of leader
and follower, pervades a high-quality joint activity routine. It is
quite natural to view this ever-present synchrony in terms of a
focus on shared nuanced rhythms.
There is also a focus on rhythmicity within some of the broader
teaching practices of the ESDM; for example, in the way in which
a teaching session is constructed. As mentioned above, teaching is
delivered within joint activity routines. For a therapist-delivered
session, these routines are strung together within a session to
occupy a full 1- or 2-h time period. Within that time period,
therapist and child move around to occupy several spaces. In a
well-coordinated way, they engage together in a joint activity rou-
tine at the table, and then may move onto the floor for the next.
They may sit together, then they may stand or walk or run. The
child’s level of arousal is carefully monitored, and the session is
marked by alternations of quiet thoughtfulness and active play,
all coordinated artfully by a skilled adult. All of these changes
occur against a stable background, as the session is marked by
stability and continuity, with the introduction of variants when
appropriate. The ESDM, a comprehensive, behavioral, and devel-
opmental early intervention designed for infants and toddlers with
autism, is rooted within a sense of and appreciation for rhythmic-
ity and synchrony at multiple levels, ranging from the specific
skills that are taught to how those skills are taught, woven together
and supported by a broader structure focused on maintaining a
well-coordinated, synchronous set of dyadic interactions.
CONCLUSION: TOWARD AN INTEGRATIVE APPROACH
COMBINING THE USE OF MELATONIN WITH THE ESDM
Taken all together, ASD could be seen as a disorder of rhyth-
micity with, more specifically, impairments in the synchrony of
rhythms. Alternatively, such asynchrony might play an important
role in a possibly large subgroup of individuals that forms part
of the heterogeneous ASD category. In this article, we proposed
an integrative approach to study desynchronization in biological
and psychological rhythms in ASD and develop an etiopathogenic
hypothesis as well as therapeutic perspectives for ASD based on
this integrative approach. Indeed, this integrated physiological and
psychological approach opens important therapeutic perspectives
for ASD based on regulation of physiological rhythms (in par-
ticular, through the use of chronobiotics such as melatonin, and
also through light exposure, use of regularly scheduled bedtime,
wake up, meals, or activities) combined with synchronization of
motor, emotional, and relational rhythms through developmen-
tal behavioral intervention such as the ESDM. Further studies are
required to better ascertain the underlying mechanisms of physio-
logical alterations induced by temporal desynchronization and to
better understand the role of biological rhythms and rhythmicity
in the development of social communication, repetitive behav-
iors, and interests or adaptation to changes, and therefore in the
development of autism involving impairments in these domains.
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